Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Monday 28 October 2019

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Interview with Tim Conder, COO of Tilt Holdings Inc. (CSE: $TILT.C)


Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Interview with Tim Conder, COO of Tilt Holdings Inc. (CSE: $TILT.C)



Delta, Kelowna, BC –October 28, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts

In today’s podcast I interview Tim Conder, the COO of Tilt Holdings Inc. (CSE: TILT) (OTCQB: TLLTF), where we discussed some of the company’s more recent news developments as well as the cannabis industry as a whole.

The company just recently announced the appointment of Tim Conder, the Company’s Chief Operating Officer and co-founder of supply-chain technology and operations asset Blackbird Logistics Corporation, to the Company’s Board of Directors.

While serving as COO of the Company, Mr. Conder has been instrumental in implementing foundational changes to the Company that have led to increased revenue, specifically in the Company’s plant-touching assets, as well as guiding the integration of technology asset Baker Technologies Inc. into Blackbird.

TILT Holdings serves cannabis brands worldwide through a strong network of portfolio companies committed to technological innovations that support long-term success. TILT services more than 2,000 brands and cannabis retailers across 33 states in the U.S., as well as in Canada, Israel, Mexico, South America and the European Union. As a market leader in cannabis technology and related products and services, the Company’s core assets include wholly-owned subsidiaries Jupiter, a company that focuses on the vast potential of inhalation through innovative design, development and manufacturing; Blackbird, a company that provides operations and software solutions for wholesale and retail distribution; and Baker, a CRM platform helping dispensaries grow their business. The Company also owns cannabis operations in states including Massachusetts, led by Commonwealth Alternative Care, Inc.; and in Pennsylvania, led by Standard Farms, LLC. Headquartered in Cambridge, Massachusetts, with offices throughout the U.S., and London, TILT has over 400 employees and has sales in the U.S., Canada and Europe.

The company also recently announced that its plant-touching operating asset Commonwealth Alternative Care received local approval(i) for adult-use cannabis sales at its retail store in Taunton, Massachusetts.

CAC began selling cannabis to patients through the Massachusetts Medical Use of Marijuana program in August of 2018. Legislation in Massachusetts was passed in late 2016 legalizing adult-use cannabis although the program faced delays and sales only began in November of 2018. CAC has been working closely with local regulatory bodies and the state’s Cannabis Control Commission (“CCC”) in order to process an application to allow Massachusetts residents above the age of 21 to purchase cannabis products at its retail outlet in Taunton. The approval is conditional pending completion of a few milestones for CAC as well as final approval from the CCC, which the Company hopes to receive in the coming months.

With almost 7 million residents, the Massachusetts cannabis market is expected to exceed $1 billion by next year. The Company has a noteworthy early-mover advantage in this “limited-license” market as one of the first to have vertically integrated operations from its production facility in the same city.

When asked about what investors can look for in the coming months in the cannabis sector and from Tilt Holdings specifically, Tim commented, “I think from the cannabis sector in general, investors can look for long term/ rapid growth. I think cannabis is still the fastest growing industry in the world and I don’t see that slowing down anytime soon. For Tilt Holdings specifically, we’re looking to hitch our wagon to that growth through our software services and hardware offerings. I think investors can expect to see from Tilt, a refined focus around technology and innovation and our continued scaling to support brands worldwide.” 

For more information on Tilt Holdings Inc. visit their website here.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411

  

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory







Breaking #Cannabis #Stock News - Isracann Biosciences (CSE: $IPOT.C) Launches Phase One Facility Development Program in Israel


Breaking #Cannabis #Stock News - Isracann Biosciences (CSE: $IPOT.C) Launches Phase One Facility Development Program in Israel

Company aims to develop top regional cannabis brands for entry into EU marketplace



VANCOUVER BC, October 28, 2019 (Investorideas.com Newswire) - Isracann Biosciences Inc.  (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) is pleased to provide an operative overview and update regarding facility development activities in Israel.

Concurrent to and as part of the Company’s recent listing on the Canadian Securities Exchange it had satisfied the escrow release conditions for the net proceeds of its highly successful CAD$10.1 million financing efforts which bolstered an already healthy cash position.

This positions the company to immediately accelerate its planned Phase One Facility Design and Construction Services Program which consists of finalization of greenhouse facility design for cannabis cultivation and production in accordance with an existing technical specifications strategy; to rapidly advance greenhouse and related facility construction per the design; ensure adequate controls are in place against any diversion, theft and loss of cannabis products per regulatory standards; and ensure compliance with other protective security, health, and safety requirements in accordance with Israeli regulations.


To-date Isracann has entered into agreements for the development of medical cannabis cultivation projects with regional stakeholders holding preliminary breeding and cultivation licenses issued by the Israeli Ministry of Health. The regional stakeholder is required to renew these licenses each year and further bears the cost of electricity, property and related land taxes and are bound to working with Isracann to obtain the required licenses and to participate in the construction of the greenhouses.

Company CEO Darryl Jones notes, “We are very pleased to have achieved our very important initial milestone targets with the CSE listing of our ticker symbol “IPOT” and to confirm our accelerated investment plans in Israel are fully under way. We have lined up several key organizations and personnel and look forward to announcing a number of these key commercial agreements in the days and weeks ahead. We thank all our supporters for their belief in us, and in our belief that the Israeli agricultural sector will provide a huge leading role in positioning the Isracann brand as market leaders in the massive and underserved European cannabis marketplace.”

In related news, the Company welcomes the recent appointment of Irit Arbel, Ph.D. to its Board of Directors. Dr. Arbel brings significant senior multidisciplinary biopharma and governance experience to Isracann’s board. She serves as CEO, Co-Founder and Director of Neurocords Ltd., a company focused on developing new treatments for peripheral and spinal cord regeneration, and previously served as Director and President of Brainstorm Cell Therapeutics, and as Executive Vice President of Research and Development at Savicell Diagnostic, a biotechnology company. Dr. Arbel previously served as Chairperson of Real Aesthetics, a company specializing in cellulite ultrasound treatment, and BRH Medical, a developer of medical devices for wound healing. She was also Director of M&A at RFB Investment House, a private investment firm focusing on early-stage technology-related companies. Previously, Dr. Arbel was President and Chief Executive Officer of Pluristem Life Systems, a biotechnology company, and prior to that as Israeli Sales Manager of Merck, Sharp & Dohme, a pharmaceutical company. Dr. Arbel earned her Ph.D. in 1997 in Neurobiology, after performing research in the area of MS. Dr. Arbel also holds a Chemical Engineering degree from the Technion, Israel’s Institute of Technology.

ON BEHALF OF THE BOARD OF DIRECTORS
“Darryl Jones”
Darryl Jones
Chief Executive Officer and President

About Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED)
Isracann is an Israeli-based cannabis company focused on becoming a premier cannabis producer offering low-cost production targeting undersupplied, major European marketplaces. Based in Israel's agricultural sector, Isracann will leverage its development within the most experienced country in the world with respect to cannabis research. The Company has secured agreements within Israel for medicinal marijuana cultivation. For more information visit: www.isracann.com.  

The CSE does not accept responsibility for the adequacy or accuracy of this release.

All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ, materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time with the Canadian Securities Exchange, the British Columbia Securities Commission, the Ontario Securities Commission, and the Alberta Securities Commission.

Contact
Investor Relations
Toll Free: +1 855.205.0226

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring CSE: IPOT is a paid for news release on Investorideas.com ($750) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories





Wednesday 23 October 2019

Investorideas.com - Cannabis stock news: MedXtractor Corp. (CSE: MXT) Announces Listing on the CSE

Investorideas.com - Cannabis stock news: MedXtractor Corp. (CSE: MXT) Announces Listing on the CSE

Investorideas.com - Canadian Cannabis Stock News: HEXO Corp (TSX: $HEXO.TO) (NYSE: $HEXO) announces $70 million private placement of convertible debentures led by Directors, CEO, and long-term shareholders; reschedules FY 2019 earnings call

Investorideas.com - Canadian Cannabis Stock News: HEXO Corp (TSX: $HEXO.TO) (NYSE: $HEXO) announces $70 million private placement of convertible debentures led by Directors, CEO, and long-term shareholders; reschedules FY 2019 earnings call

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE: $CHOO.C), (OTCQB: $CLSK), (TSX: $RIV.TO), (CSE: $TER.C), (CSE: $COOL.C), (OTCQX: $CLABF)


Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE: $CHOO.C), (OTCQB: $CLSK), (TSX: $RIV.TO), (CSE: $TER.C), (CSE: $COOL.C), (OTCQX: $CLABF)



Delta, Kelowna, BC –October 23, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts

In today’s podcast we look at a few of today’s early announcements.

But first, Province Brands of Canada, a leading researcher in cannabinoid science and the developer of first-of-their-kind luxury beverages powered by cannabis, is proud to announce today the filing of a patent application in the United States (and soon to be expanded globally) for a novel strain of yeast designed to improve the Company's first-of-its-kind process for the fermentation of cannabis and help Province Brands bring the world's first beverages brewed from cannabis (in place of the seed or fruit of cereal grasses) to market.  This is the second patent in progress for Province Brands of Canada.

The invention of, a strain of Scheffersomyces (Pichia) stipitis, already on file with the International Depositary Authority of Canada, is a novel proprietary technology which will allow the Company to more efficiently convert the stalks, stems and roots of the cannabis plant into a fermented beverage.

Nearly every commercially produced brewers' yeast has been specifically engineered to ferment sugars from seed or fruit of cereal grasses (barley, wheat, rice, etc.),  or pure sugars.  Prior to the development of this yeast, Province Brands of Canada was limited to only working with these commercially available yeasts and was not able to achieve full fermentation of cannabis stalks, stems & roots.  While it was still possible for Province Brands to brew delicious beverages using these commercially available yeasts, costly additional steps were required to remove unwanted byproducts of the fermentation. A strain of S.  stipitis enables Province Brands to achieve a complete fermentation from cannabis stalks, stems and roots, lowering the costs, and improving flavor & product quality.

Brewed beverages containing cannabis are expected to see explosive growth once Canada becomes the first country in the world to allow for the sale of recreational cannabis edibles and beverages at a federal level later this year (edibles and beverages are allowed in certain U.S. States, but not allowed federally).  This new proprietary yeast will allow Province Brands of Canada to more efficiently brew its beverages – which are in an entirely different category from the competition.  Other brewed beverages will be fermented from barley, grains or sugar and infused with marijuana oil.  This process may result in products that are unpredictable, unattractive and bad tasting.  Province Brands uses no barley, sugar or grains and instead ferments cannabis plant matter to create the best-tasting, highest-quality brewed cannabis beverages available.

"The yeast themselves produce abundant flavor compounds and are signature to a beer. This technology allows Province Brands to combine traits of yeast cousins to improve the organoleptic qualities of their beers, produced from cannabis, to be distinctive and exclusive. I believe that the technology here is complimentary to Province Brands of Canada's existing collection of technologies and previous developments," said Dr. Erin Johnson, developer of the technology.

The patent application also involves biotechnology that selects and isolates the proprietary strains of yeast, should allow Province Brands of Canada to create the best-tasting, highest quality brewed cannabis beverages available.

CleanSpark, Inc. (OTCQB: CLSK), a microgrid company with advanced engineering, software and controls for innovative distributed energy resource management systems, today announced it has received an engineering contract as a result of a previously announced project feasibility study. The engineering contract is for the creation of an independent and comprehensive power system for an indoor, controlled distribution cannabis grow facility in California. The engineering contract is expected to be completed by the end of October.

“The execution of the engineering contract comes as a result of the successful feasibility study backed by our mVSO software” said Mr. Zach Bradford, CleanSpark’s President and CEO. “Our mVSO software was used to determine the appropriate energy storage, solar PV system sizes, projected utility savings, capital costs, operations and maintenance costs and a 20-year economic financial model depicting the project’s return on investment, cash flows and tax effects. This is a critical part of project analysis and our software solution helps to determine the overall economics of any microgrid project. Our analysis showed that this is a feasible and economic project and as a result it is now moving to the engineering stage with our assistance. We expect successful completion will lead to additional revenue opportunities for energy storage procurement and our controller and mPulse Software in the six-figure range.

Mr. Bradford continued, “mPulse™ will provide active controls to increase site-wide performance through real-time decision making based on forecasted power system needs and optimization of the resources used in the microgrid. mPulse makes the microgrid intelligent and more efficient, which is what customers will increasingly demand as the microgrid megatrend continues.”

Mr. Bradford concluded, “The cannabis industry continues to be one of the prime market opportunities for our solutions as the remote location of many grow facilities and large power consumption needs create significant challenges for the industry. This often makes a microgrid and independent power production the optimal solution for reliability and scale and presents us with the opportunity to leverage our products and software in a high growth sector of the market.”

Choom™ (CSE: CHOO) (OTCQB: CHOOF), an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, announced that it has secured a Development Permit for a retail location at 191 W. 2nd Ave, Vancouver BC.
Corey Gillon, President states, "Choom is thrilled to have secured a location for Choom's Flagship store in the City of Vancouver, and with it, the opportunity to bring a Choom retail store to the Olympic Village community of Vancouver. Initially constructed for the 2010 Winter Olympics, Olympic Village has transformed into a vibrant and dynamic community, and we're excited to bring a gold medal retail experience to residents and visitors of this fantastic community."

The location has received a development permit and the required Board of Variance approval from the City of Vancouver to operate a recreational retail cannabis store. Choom has submitted its application for a recreational retail cannabis store license to the Liquor & Cannabis Regulation Branch of the Province of British Columbia.

Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, and Kindred Partners Inc., a specialty cannabis brokerage and services company, today announced a strategic alliance established to provide mutual benefits to Canopy Rivers, its portfolio companies, and Kindred.

Kindred, a wholly-owned subsidiary of Breakthru Beverage Group, leverages the deep experience of its sister company, Breakthru Beverage Canada, in working with Canadian provincial control boards, public and private regulated cannabis businesses, licensed producers and retailers to broker regulated cannabis products for the adult-use market.

"As we head into cannabis 2.0 and the Canadian cannabis market continues to develop in a highly regulated environment, we expect that distribution will be one of the key tenets of success for brands," said Narbé Alexandrian, President & CEO, Canopy Rivers. "Our strategic alliance with Kindred presents a valuable opportunity for our portfolio companies to access the expertise and distribution channels necessary to enable their branded products to thrive. We're excited to work with Kindred, alongside our portfolio, to unlock the industry's long-term potential."

The agreement affords Canopy Rivers' portfolio of current and future licensed producers access to Kindred's brokerage, marketing, and brand-building services. Kindred will provide strategic benefits to Canopy Rivers through its network and team of marketing and branded product experts, insights from Kindred's industry-leading enterprise resource planning and marketing intelligence infrastructure, and brokered distribution to Canopy Rivers' portfolio companies at scale via Kindred's already established national sales platform.

As part of the strategic alliance, Julian Burzynski, Regional President of Breakthru Beverage Canada, has joined Canopy Rivers' recently launched Strategic Advisory Board. With nearly 30 years' experience in the alcohol beverage industry, Mr. Burzynski will provide Canopy Rivers with insights related to beverage brokerage, distribution, and go-to-market strategies.

"This is a great opportunity to expand our influence in the Canadian adult-use marketplace and leverage our network to help innovative brands thrive," said David Prodanovic, Kindred's General Manager. "We are thrilled to partner with Canopy Rivers and look forward to collaborating with its portfolio companies."

TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) also announced that it has formed a strategic partnership with Kindred Partners Inc. where Kindred will serve as the exclusive broker for TerrAscend's adult-use cannabis products in Canada. The agreement will help bolster distribution and drive sales for TerrAscend by leveraging Kindred's brokerage, marketing and brand-building services, as well as its consumer insights and data.

"Our strategic partnership with Kindred ensures that TerrAscend has direct access to distribution channels and consumer insights that are critical for our products to thrive in an evolving cannabis industry, particularly as we head into cannabis 2.0," said Michael Nashat, CEO of TerrAscend. "We are looking forward to tapping into Kindred's national network and team of specialists as we take advantage of the imminent legal sales of cannabis-infused products."

The new partnership with Kindred follows a number of important developments for TerrAscend Canada. The Company recently received Health Canada approval for a nearly three-fold expansion of licensed space at its EU-GMP certified facility in Mississauga, Ontario, which will allow for new product formats and extracts for the adult-use market, as well as expanded distribution opportunities. Additionally, the Company received an amendment to its license from Health Canada to allow it to sell cannabis extracts, topicals and edibles. Sales of TerrAscend's new product formats will begin in December, pending Health Canada authorization.

TerrAscend also applauds venture capital firm Canopy Rivers Inc. and Kindred on their strategic alliance, announced earlier today. TerrAscend is an active participant in the Canopy Rivers ecosystem, having significant purchase and supply agreements with other Canopy Rivers portfolio companies, including PharmHouse Inc. and James E. Wagner Cultivation Corporation. Canopy Rivers first invested in TerrAscend in 2017, restructuring their initial investment last year to allow for strategic international expansion. Earlier this month, Canopy Rivers announced an additional US$10 million investment in TerrAscend Canada Inc.

"We are excited to represent TerrAscend's innovative products and share insights to help them address the adult-use market," said Dave Prodanovic, Kindred's General Manager. "We will leverage our deep experience and talented team to offer brand-building and go-to-market execution that will provide nationwide visibility to TerrAscend's adult-use cannabis brands."

Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) announced that it has signed a non-binding letter of intent (the "LOI") to acquire all of the outstanding shares of 1210950 B.C. Ltd. dba Rainy Daze Cannabis Corp. in exchange for a cash payment of CAD$100,000 and 3,500,000 shares of the Company's common stock.

Rainy Daze was organized by the CEO of a fully-licensed Canadian LP with current Cultivation and Medical Sales licenses. Rainy Daze facility has a license application in process. The facility used by Rainy Daze is held under a long term lease and is currently under construction and is scheduled to be completed in the 2nd quarter of 2020. Once completed, the facility will include 22,510 sq. ft. of canopy space and 3,500 sq. ft. of operational purpose-built building.

The facility will be operated by experienced staff with LP credentials, and will include 15 top proprietary genetics, together with the farming resources and SOPs to ensure compliance and maximum yield, seed to sale software, and secured distribution agreements that guarantee shelf space with a group of over 12 licensed locations in western Canada. With extraction capabilities onsite, the acquisition will provide Core One Labs an opportunity to enter the edibles and extracts markets and independently brand all of the Company's products in the Canadian market.

The completion of the transaction is subject to a satisfactory due-diligence process, which is expected to be completed by November 30, 2019.

The CEO of Core One Labs Inc., Brad Eckenweiler, commented, "With completion of this proposed transaction, Core One Labs will have a clear and defined path to the Canadian market and ultimately the ability to export CannaStrips™ internationally.  The location and extensive capabilities of the Rainy Daze facility is uniquely suited to meet the goals and aspirations of the Core One Labs team." The Company will continue to update the market on the progress of this transaction as it proceeds to the completion of the acquisition.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411

  


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory






You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB) : You can't hold a good weed stock down (Nasdaq: CG...